Max A. Milbury's most recent trade in ProMIS Neurosciences Inc. was a trade of 6,595 Common Shares done at an average price of $12.1 . Disclosure was reported to the exchange on Feb. 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProMIS Neurosciences Inc | Max A. Milbury | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 12.13 per share. | 03 Feb 2026 | 6,595 | 8,409 | - | 12.1 | 79,997 | Common Shares |
| ProMIS Neurosciences Inc | Max A. Milbury | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2026 | 6,595 | 6,595 | - | - | Warrants to purchase Common Shares | |
| ProMIS Neurosciences Inc | Max A. Milbury | Principal Accounting Officer | Purchase of securities on an exchange or from another person at price $ 0.49 per share. | 03 Oct 2025 | 30,392 | 45,389 | - | 0.5 | 14,929 | Common Shares |
| ProMIS Neurosciences Inc | Max A. Milbury | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2025 | 60,000 | 60,000 | - | - | Option (right to buy) | |
| ProMIS Neurosciences Inc | Max A. Milbury | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2024 | 70,000 | 70,000 | - | - | Option (right to buy) | |
| ProMIS Neurosciences Inc | Max A. Milbury | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 13,297 | 14,997 | - | - | Common Shares | |
| ProMIS Neurosciences Inc | Max A. Milbury | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 13,297 | 13,297 | - | - | Warrants to purchase Common Shares |